1h Free Analyst Time
The publisher has been monitoring the blood glucose test strips market and it is poised to grow by $6.77 bn during 2021-2025, progressing at a CAGR of almost 10% during the forecast period. The report on blood glucose test strips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the number of diabetes cases and rising awareness about diabetes and growth of new marketing strategies In addition, increase in the number of diabetes cases and rising awareness about diabetes is anticipated to boost the growth of the market as well.
The blood glucose test strips market analysis includes end-user segment and geographic landscape.
The blood glucose test strips market is segmented as below:
By End-user
- Hospitals and diagnostic laboratories
- Home care settings
- POL
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies the availability of products on online channels as one of the prime reasons driving the blood glucose test strips market growth during the next few years.
The report on blood glucose test strips market covers the following areas:
- Blood glucose test strips market sizing
- Blood glucose test strips market forecast
- Blood glucose test strips market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose test strips market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Omnis Health LLC, Sanofi SA, Sinocare Inc., Teladoc Health Inc., and UniStrip Technologies LLC. Also, the blood glucose test strips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global blood glucose test strips market: Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Omnis Health LLC, Sanofi SA, Sinocare Inc., Teladoc Health Inc., and UniStrip Technologies LLC.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the availability of products on online channels.'
According to the report, one of the major drivers for this market is the increase in the number of diabetes cases and rising awareness about diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- F. Hoffmann-La Roche Ltd.
- LifeScan IP Holdings LLC
- Omnis Health LLC
- Sanofi SA
- Sinocare Inc.
- Teladoc Health Inc.
- UniStrip Technologies LLC